Alma Therapeutics
Tel Aviv, Israel· Est.
Platform company turning injectable biologics into oral pills to revolutionize chronic disease therapy.
Is this your company? Claim your profile to update info and connect with investors.
Claim profilePrivate Company
Funding information not available
AI Company Overview
Platform company turning injectable biologics into oral pills to revolutionize chronic disease therapy.
Technology Platform
The Alma Smart Capsule protects biologic macromolecules through the GI tract and enables systemic absorption, converting injectable drugs into oral pills.
Opportunities
Successful oral delivery of biologics could open multi‑billion‑dollar markets and attract large‑pharma licensing deals.
Risk Factors
Regulatory approval and consistent bioavailability for high‑molecular‑weight therapeutics remain significant technical and clinical hurdles.
Competitive Landscape
Few companies have proven oral biologic platforms; Alma differentiates through its capsule technology and extensive patent portfolio.